Lifestyle Drugs Market - Forecast(2024 - 2030)

Report Code: HCR 0290 Report Format: PDF + Excel
The Lifestyle Drugs Market size is estimated to reach $77373.9 million by 2030, growing at a CAGR of 10.20% during the forecast period 2024-2030. Lifestyle style drugs are defined as medicines which are used to treat diseases arise due to lifestyle illnesses or habits such as smoking, alcoholism or unhealthy diet habits. Lifestyle medicines are aimed at improving person’s quality of life by treating conditions that are not lethal or non-painful which include baldness, wrinkles, impotence, acne, weight loss, insomnia, and others. Over the past few years, lifestyle drugs have become commercially attractive and one of the most dynamic industries across the globe. Growing popularity of lifestyle drugs is primarily driven by attributors such as increase in stamina, memory, concentration and energy level which are of prime need among youth and middle aged population owing to stressful and unhealthy lifestyle.
 
Lifestyle Drugs Market

Geographically North America dominated global lifestyle drugs market, due to higher awareness about lifestyle related disease, better healthcare infrastructure and better spending power of its citizens. North America was followed by Europe and Asia-Pacific as second and third largest market of lifestyle drugs. Asia Pacific is projected to have fastest growth, owing to rapidly changing lifestyle of the people in the region due to industrialization and developing health care coupled with increasing awareness in developing nations such as China, and India in this region. Among all the drug class weight loss related drugs is expected to have fastest growth during the period of study.

This report identifies the global lifestyle drugs market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global lifestyle drugs market.

This report segments global lifestyle drugs market on the basis of disease addressed and regional market as follows:
  • Lifestyle Drugs Market, By Disease: Erectile dysfunction, Balding, Weight loss, Cosmetic, Focus & Energy, Birth Control, Smoking Cessation, and Others
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the lifestyle drugs market. Some of the major companies’ profiles in detail are as follows:
  • Mylan pharmaceuticals
  • GlaxoSmithKline
  • McNeil
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Dr. Reddy’s Laboratories
  • Eli Lilly
  • Bristol-Myers-Squibb
  • Pfizer

1. Lifestyle Drugs Market – Market Overview
2. Executive Summary
3. Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Lifestyle Drugs Market– Market Forces
   4.1. Drivers
      4.1.1. Growing population with lifestyle related health issues
      4.1.2. Increasing spending for fitness and health
   4.2. Restraints
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Lifestyle Drugs Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Lifestyle Drugs Market, By Disease
   6.1. Erectile dysfunction
   6.2. Balding
   6.3. Weight loss
   6.4. Cosmetic
   6.5. Focus & Energy
   6.6. Birth Control
   6.7. Smoking Cessation
   6.8. Others
7. Lifestyle Drugs Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Lifestyle Drugs – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   9.1. Pfizer Inc.
   9.2. Eli Lily
   9.3. Teva Pharmaceuticals
   9.4. Biocon Ltd.
   9.5. Mylan pharmaceuticals
   9.6. GlaxoSmithKline
   9.7. McNeil
   9.8. Johnson & Johnson
   9.9. Merck & Co. Inc.
   9.10. Dr. Reddy’s Laboratories
   9.11. Zydus Cadila
   9.12. Cipla
   9.13. Sun Pharmaceuticals
   9.14. Nicholas Piramal
   9.15. Alembic
   9.16. Proctor & Gamble
   9.17. Astrazeneca
   9.18. Novo Nordisk
   9.19. Amgen
   9.20. Lupin
   9.21. Bristol-Myers-Squibb

*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer

List of Tables:

Table 1: Lifestyle Drugs Market Overview 2023-2030
Table 2: Lifestyle Drugs Market Leader Analysis 2023-2030 (US$)
Table 3: Lifestyle Drugs Market Product Analysis 2023-2030 (US$)
Table 4: Lifestyle Drugs Market End User Analysis 2023-2030 (US$)
Table 5: Lifestyle Drugs Market Patent Analysis 2013-2023* (US$)
Table 6: Lifestyle Drugs Market Financial Analysis 2023-2030 (US$)
Table 7: Lifestyle Drugs Market Driver Analysis 2023-2030 (US$)
Table 8: Lifestyle Drugs Market Challenges Analysis 2023-2030 (US$)
Table 9: Lifestyle Drugs Market Constraint Analysis 2023-2030 (US$)
Table 10: Lifestyle Drugs Market Supplier Bargaining Power Analysis 2023-2030 (US$)
Table 11: Lifestyle Drugs Market Buyer Bargaining Power Analysis 2023-2030 (US$)
Table 12: Lifestyle Drugs Market Threat of Substitutes Analysis 2023-2030 (US$)
Table 13: Lifestyle Drugs Market Threat of New Entrants Analysis 2023-2030 (US$)
Table 14: Lifestyle Drugs Market Degree of Competition Analysis 2023-2030 (US$)
Table 15: Lifestyle Drugs Market Value Chain Analysis 2023-2030 (US$)
Table 16: Lifestyle Drugs Market Pricing Analysis 2023-2030 (US$)
Table 17: Lifestyle Drugs Market Opportunities Analysis 2023-2030 (US$)
Table 18: Lifestyle Drugs Market Product Life Cycle Analysis 2023-2030 (US$)
Table 19: Lifestyle Drugs Market Supplier Analysis 2023-2030 (US$)
Table 20: Lifestyle Drugs Market Distributor Analysis 2023-2030 (US$)
Table 21: Lifestyle Drugs Market Trend Analysis 2023-2030 (US$)
Table 22: Lifestyle Drugs Market Size 2023 (US$)
Table 23: Lifestyle Drugs Market Forecast Analysis 2023-2030 (US$)
Table 24: Lifestyle Drugs Market Sales Forecast Analysis 2023-2030 (Units)
Table 25: Lifestyle Drugs Market, Revenue & Volume, By Disease, 2023-2030 ($)
Table 26: Lifestyle Drugs Market By Disease, Revenue & Volume, By Erectile dysfunction, 2023-2030 ($)
Table 27: Lifestyle Drugs Market By Disease, Revenue & Volume, By Balding, 2023-2030 ($)
Table 28: Lifestyle Drugs Market By Disease, Revenue & Volume, By Weight loss, 2023-2030 ($)
Table 29: Lifestyle Drugs Market By Disease, Revenue & Volume, By Cosmetic, 2023-2030 ($)
Table 30: Lifestyle Drugs Market By Disease, Revenue & Volume, By Focus & Energy, 2023-2030 ($)
Table 31: North America Lifestyle Drugs Market, Revenue & Volume, By Disease, 2023-2030 ($)
Table 32: South america Lifestyle Drugs Market, Revenue & Volume, By Disease, 2023-2030 ($)
Table 33: Europe Lifestyle Drugs Market, Revenue & Volume, By Disease, 2023-2030 ($)
Table 34: APAC Lifestyle Drugs Market, Revenue & Volume, By Disease, 2023-2030 ($)
Table 35: Middle East & Africa Lifestyle Drugs Market, Revenue & Volume, By Disease, 2023-2030 ($)
Table 36: Russia Lifestyle Drugs Market, Revenue & Volume, By Disease, 2023-2030 ($)
Table 37: Israel Lifestyle Drugs Market, Revenue & Volume, By Disease, 2023-2030 ($)
Table 38: Top Companies 2023 (US$) Lifestyle Drugs Market, Revenue & Volume
Table 39: Product Launch 2023-2030 Lifestyle Drugs Market, Revenue & Volume
Table 40: Mergers & Acquistions 2023-2030 Lifestyle Drugs Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Lifestyle Drugs Market 2023-2030
Figure 2: Market Share Analysis for Lifestyle Drugs Market 2023 (US$)
Figure 3: Product Comparison in Lifestyle Drugs Market 2023-2030 (US$)
Figure 4: End User Profile for Lifestyle Drugs Market 2023-2030 (US$)
Figure 5: Patent Application and Grant in Lifestyle Drugs Market 2013-2023* (US$)
Figure 6: Top 5 Companies Financial Analysis in Lifestyle Drugs Market 2023-2030 (US$)
Figure 7: Market Entry Strategy in Lifestyle Drugs Market 2023-2030
Figure 8: Ecosystem Analysis in Lifestyle Drugs Market 2023
Figure 9: Average Selling Price in Lifestyle Drugs Market 2023-2030
Figure 10: Top Opportunites in Lifestyle Drugs Market 2023-2030
Figure 11: Market Life Cycle Analysis in Lifestyle Drugs Market
Figure 12: GlobalBy DiseaseLifestyle Drugs Market Revenue, 2023-2030 ($)
Figure 13: Global Lifestyle Drugs Market - By Geography
Figure 14: Global Lifestyle Drugs Market Value & Volume, By Geography, 2023-2030 ($) 
Figure 15: Global Lifestyle Drugs Market CAGR, By Geography, 2023-2030 (%)
Figure 16: North America Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 17: US Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 18: US GDP and Population, 2023-2030 ($)
Figure 19: US GDP – Composition of 2023, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2023-2030 ($)
Figure 21: Canada Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 22: Canada GDP and Population, 2023-2030 ($)
Figure 23: Canada GDP – Composition of 2023, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2023-2030 ($)
Figure 25: Mexico Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 26: Mexico GDP and Population, 2023-2030 ($)
Figure 27: Mexico GDP – Composition of 2023, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2023-2030 ($)
Figure 29: South America Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 30: Brazil Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 31: Brazil GDP and Population, 2023-2030 ($)
Figure 32: Brazil GDP – Composition of 2023, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2023-2030 ($)
Figure 34: Venezuela Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 35: Venezuela GDP and Population, 2023-2030 ($)
Figure 36: Venezuela GDP – Composition of 2023, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2023-2030 ($)
Figure 38: Argentina Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 39: Argentina GDP and Population, 2023-2030 ($)
Figure 40: Argentina GDP – Composition of 2023, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2023-2030 ($)
Figure 42: Ecuador Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 43: Ecuador GDP and Population, 2023-2030 ($)
Figure 44: Ecuador GDP – Composition of 2023, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2023-2030 ($)
Figure 46: Peru Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 47: Peru GDP and Population, 2023-2030 ($)
Figure 48: Peru GDP – Composition of 2023, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2023-2030 ($)
Figure 50: Colombia Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 51: Colombia GDP and Population, 2023-2030 ($)
Figure 52: Colombia GDP – Composition of 2023, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2023-2030 ($)
Figure 54: Costa Rica Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 55: Costa Rica GDP and Population, 2023-2030 ($)
Figure 56: Costa Rica GDP – Composition of 2023, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2023-2030 ($)
Figure 58: Europe Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 59: U.K Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 60: U.K GDP and Population, 2023-2030 ($)
Figure 61: U.K GDP – Composition of 2023, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2023-2030 ($)
Figure 63: Germany Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 64: Germany GDP and Population, 2023-2030 ($)
Figure 65: Germany GDP – Composition of 2023, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2023-2030 ($)
Figure 67: Italy Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 68: Italy GDP and Population, 2023-2030 ($)
Figure 69: Italy GDP – Composition of 2023, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2023-2030 ($)
Figure 71: France Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 72: France GDP and Population, 2023-2030 ($)
Figure 73: France GDP – Composition of 2023, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2023-2030 ($)
Figure 75: Netherlands Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 76: Netherlands GDP and Population, 2023-2030 ($)
Figure 77: Netherlands GDP – Composition of 2023, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2023-2030 ($)
Figure 79: Belgium Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 80: Belgium GDP and Population, 2023-2030 ($)
Figure 81: Belgium GDP – Composition of 2023, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2023-2030 ($)
Figure 83: Spain Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 84: Spain GDP and Population, 2023-2030 ($)
Figure 85: Spain GDP – Composition of 2023, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2023-2030 ($)
Figure 87: Denmark Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 88: Denmark GDP and Population, 2023-2030 ($)
Figure 89: Denmark GDP – Composition of 2023, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2023-2030 ($)
Figure 91: APAC Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 92: China Lifestyle Drugs Market Value & Volume, 2023-2030
Figure 93: China GDP and Population, 2023-2030 ($)
Figure 94: China GDP – Composition of 2023, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2023-2030 ($)Lifestyle Drugs Market China Export and Import Value & Volume, 2023-2030 ($)
Figure 96: Australia Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 97: Australia GDP and Population, 2023-2030 ($)
Figure 98: Australia GDP – Composition of 2023, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2023-2030 ($)
Figure 100: South Korea Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 101: South Korea GDP and Population, 2023-2030 ($)
Figure 102: South Korea GDP – Composition of 2023, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2023-2030 ($)
Figure 104: India Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 105: India GDP and Population, 2023-2030 ($)
Figure 106: India GDP – Composition of 2023, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2023-2030 ($)
Figure 108: Taiwan Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 109: Taiwan GDP and Population, 2023-2030 ($)
Figure 110: Taiwan GDP – Composition of 2023, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2023-2030 ($)
Figure 112: Malaysia Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 113: Malaysia GDP and Population, 2023-2030 ($)
Figure 114: Malaysia GDP – Composition of 2023, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2023-2030 ($)
Figure 116: Hong Kong Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 117: Hong Kong GDP and Population, 2023-2030 ($)
Figure 118: Hong Kong GDP – Composition of 2023, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2023-2030 ($)
Figure 120: Middle East & Africa Lifestyle Drugs Market Middle East & Africa 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 121: Russia Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 122: Russia GDP and Population, 2023-2030 ($)
Figure 123: Russia GDP – Composition of 2023, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2023-2030 ($)
Figure 125: Israel Lifestyle Drugs Market Value & Volume, 2023-2030 ($)
Figure 126: Israel GDP and Population, 2023-2030 ($)
Figure 127: Israel GDP – Composition of 2023, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2023-2030 ($)
Figure 129: Entropy Share, By Strategies, 2023-2030* (%)Lifestyle Drugs Market
Figure 130: Developments, 2023-2030*Lifestyle Drugs Market
Figure 131: Company 1 Lifestyle Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 132: Company 1 Lifestyle Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 133: Company 1 Lifestyle Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 134: Company 2 Lifestyle Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 135: Company 2 Lifestyle Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 136: Company 2 Lifestyle Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 137: Company 3 Lifestyle Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 138: Company 3 Lifestyle Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 139: Company 3 Lifestyle Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 140: Company 4 Lifestyle Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 141: Company 4 Lifestyle Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 142: Company 4 Lifestyle Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 143: Company 5 Lifestyle Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 144: Company 5 Lifestyle Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 145: Company 5 Lifestyle Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 146: Company 6 Lifestyle Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 147: Company 6 Lifestyle Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 148: Company 6 Lifestyle Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 149: Company 7 Lifestyle Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 150: Company 7 Lifestyle Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 151: Company 7 Lifestyle Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 152: Company 8 Lifestyle Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 153: Company 8 Lifestyle Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 154: Company 8 Lifestyle Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 155: Company 9 Lifestyle Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 156: Company 9 Lifestyle Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 157: Company 9 Lifestyle Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 158: Company 10 Lifestyle Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 159: Company 10 Lifestyle Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 160: Company 10 Lifestyle Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 161: Company 11 Lifestyle Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 162: Company 11 Lifestyle Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 163: Company 11 Lifestyle Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 164: Company 12 Lifestyle Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 165: Company 12 Lifestyle Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 166: Company 12 Lifestyle Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 167: Company 13 Lifestyle Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 168: Company 13 Lifestyle Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 169: Company 13 Lifestyle Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 170: Company 14 Lifestyle Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 171: Company 14 Lifestyle Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 172: Company 14 Lifestyle Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 173: Company 15 Lifestyle Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 174: Company 15 Lifestyle Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 175: Company 15 Lifestyle Drugs Market Net Sales Share, By Geography, 2023 (%)